Viewing Study NCT06645704


Ignite Creation Date: 2025-12-24 @ 9:14 PM
Ignite Modification Date: 2025-12-25 @ 7:03 PM
Study NCT ID: NCT06645704
Status: COMPLETED
Last Update Posted: 2025-02-24
First Post: 2024-10-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: An Open-Label Phase 1 Study in Healthy Male Subjects to Investigate the Absorption, Metabolism and Excretion of [14C]-EP262 Following Single-Dose Oral Administration
Sponsor: Escient Pharmaceuticals, Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module